Cancer Stem Cell News 9.05 February 12, 2020 | |
| |
TOP STORYA sphere-forming assay was performed to evaluate cancer stem cell traits in vitro, subcutaneous NOD/SCID mice models were generated to assess in vivo cancer stem cell features, and colony formation assays assessed drug resistance capacities. [J Hematol Oncol] Full Article | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Cell Counting Kit-8, Transwell assays, colony formation analysis and xenograft tumorigenicity assay were used to measure the nasopharyngeal CD133+ cancer stem cell proliferation, migration, and invasion abilities. [J Exp Clin Cancer Res] Full Article Scientists observed a suppressive role of SIRT1 in chemoresistance of gastric cancer both in vitro and in vivo. They found that SIRT1 eliminated cancer stem cell properties of gastric cancer cells. [Cell Death Dis] Full Article Researchers identified the downstream mediators of the stemness-stimulating effect of GATA6. LRH-1 was found as a direct target of GATA6 and its upregulation promoted the stemness in both HC-116 and HT-29 cells. [Mol Oncol] Abstract The authors found that adipose-derived stem cells fused with breast cancer cells spontaneously, while breast cancer stem cell markers CD44+CD24-/lowEpCAM+ were enriched in this fusion population. [J Cell Physiol] Abstract Fibroblasts-Dependent Invasion of Podoplanin-Positive Cancer Stem Cells in Squamous Cell Carcinoma A collagen gel invasion assay was performed using fluorescent ubiquitination-based cell cycle indicator-labeled A431 cells. The total number and number of invading cells in S/G2/M phase were counted using time-lapse imaging cocultured with fibroblasts. [J Cell Physiol] Abstract 3D Tumor Spheroids for the Prediction of the Effects of Radiation and Hyperthermia Treatments The response of tumor spheroids formed from two established human cancer cell lines to single and combination treatments of radiation, and hyperthermia at 47°C was evaluated. [Sci Rep] Full Article Investigators demonstrated that tumor necrosis factor alpha (TNF-α) up-regulated TAZ, a transcriptional co-activator promoting breast cancer stem-like cell self-renewal capacity in human breast cancer cell lines. [Sci Rep] Full Article Sphere formations on gelatin-coated culture, suspension culture, and matrigel culture were observed, and the expression of LGR5, SSEA3, SSEA4, and other stemness markers was examined. [J Biomed Sci] Full Article Subscribe to one of our other 19 science newsletters such as Neural Cell News & Hematopoiesis News. | |
| |
REVIEWSPost-Transcriptional Regulation of Homeostatic, Stressed, and Malignant Stem Cells The authors discuss how post-transcriptional mechanisms enable stem cell homeostasis and responsiveness to developmental cues and environmental stressors by rapidly shaping the content of their proteome and how these processes are disrupted in pre-malignant and malignant states. [Cell Stem Cell] Abstract Crosstalk between Autophagy and Metabolic Regulation of Cancer Stem Cells Scientists emphasize metabolic pathways in cancer stem cells and discuss how autophagy-mediated regulation metabolism is involved in their maintenance and proliferation. [Mol Cancer] Full Article Visit our reviews page to see a complete list of reviews in the cancer stem cell research field. | |
| |
INDUSTRY NEWSKite announced that the FDA has accepted the BLA and granted Priority Review designation for KTE-X19, an investigational chimeric antigen receptor T cell therapy for the treatment of adult patients with relapsed or refractory mantle cell lymphoma. [Kite (Business Wire, Inc.)] [Kite (Business Wire, Inc.)] Press Release Astex Pharmaceuticals, Inc. announced that the FDA has accepted for Priority Review its NDA for oral C-DEC as a treatment for adults with previously untreated intermediate- and high-risk myelodysplastic syndromes (MDS) including chronic myelomonocytic leukemia (CMML). [Astex Pharmaceuticals, Inc (Business Wire, Inc.)] Press Release | |
| |
POLICY NEWSTrump Proposes Significant Cuts to NIH for 2021 Budget The president’s request for next year’s federal budget includes a seven percent drop in funding for the National Institutes of Health and reductions for other science agencies. [The Scientist] Editorial Major Cancer Institute Sued by Its Own Researchers over ‘Tapering’ Funding Alleging that a leading cancer funder is slashing their support in an “unethical and reckless” way, six prominent cancer researchers at the University of California, San Diego, have filed a lawsuit to compel it to continue its current level of support. [ScienceInsider] Editorial
| |
EVENTSNEW Tumor Metabolism Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESPostdoctoral Fellow – Translational Brain Tumor Research (Northwestern University) Postdoctoral Studentship and PhD Position – Cancer Cell Plasticity (Giessen University) Postdoctoral Position – Stemness in Epigenetic Regulation (University of Freiburg) Postdoctoral Fellow – Research in Cancer Progression (The Wistar Institute) Postdoctoral Position – Bioinformatics and Leukemia Stem Cells (The Centre for Genomic Regulation) Postdoctoral Fellow – Clonal Evolution of Cancer (Moffitt Cancer Center & Research Institute) Research Fellow – Glioblastoma Cell Signaling (University of Sussex) Postdoctoral Position – Glioma and Neurodevelopment (Mount Sinai) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Cancer Stem Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|